2025³â 02¿ù 07ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 85821°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÀÌÁØÈ£, ÇÁ¶û½º Æĸ® 2025 º§·çƼ ÇÁ·¹Á¨Å×ÀÌ¼Ç Âü¼®

º§·çƼ 2025ÇÁ·¹Á¨Å×À̼Ç... 130³â°£ÀÇ °æÀÌ·Î¿î ¹ß°ÉÀ½
2025³â 1¿ù 22ÀÏ, °¡¼ö °â ¹è¿ì ÀÌÁØÈ£°¡ FW25 Æĸ® ÆÐ¼Ç À§Å©¿¡ ¿­¸° º§·çƼÀÇ »õ·Î¿î ÇÁ·¹Á¨Å×ÀÌ¼Ç Çà»ç¿Í 130ÁÖ³âÀ» ±â³äÇϱâ À§ÇÑ Ä¬Å×ÀÏ ÆÄƼ¿¡ Âü¼®ÇØ ÀÚ¸®¸¦ ºû³Â´Ù. ¿ÃÇØ  ⸳ 130ÁÖ³âÀ» ¸ÂÀº º§·çƼ´Â À̸¦ ±â³äÇϱâ À§ÇØ »ý¹° Á¾µéÀÌ °øÅë Á¶»óÀ¸·ÎºÎÅÍ ¾î¶»°Ô ºÐÈ­ÇÏ°í ¹ßÀüÇß´ÂÁö¿¡ °üÇÑ ÇÙ½É »ý¹°ÇÐÀû ¿ø¸®ÀÎ °èÅë ¹ß»ýÇÐ(Phylogeny)À̶ó´Â °³³äÀ» äÅÃÇÏ¿© º§·çƼÀÇ °øÅëµÈ »Ñ¸®¿¡¼­ ÁøÈ­ÇÑ ¼¼ °¡Áö Àü¹® ºÐ¾ß¿¡ ´ã±ä º§·çƼ °¡Á× ±â¼úÀÇ Á¤Å뼺À» ¼Ò°³ÇÑ´Ù. ÇÁ¶û½º ¹®È­¿Í Çй®¿¡ ÀÖ¾î Áß¿äÇÑ Àå¼ÒÀÎ ½Ã¸ó & Ä¡ ...

½ÅÇÑÄ«µå, »ý¼ºÇü AI žÀçÇÑ »ó´ã Áö¿ø½Ã½ºÅÛ ¡®AI-SOLa¡¯ ±¸Ãà

¹®ÀÇ ³»¿ëÀ» AI°¡ ½Ç½Ã°£À¸·Î ºÐ¼®ÇØ »ó´ã»ç¿¡°Ô ÃÖÀûÀÇ ¼Ö·ç¼Ç Á¦½Ã
½ÅÇÑÄ«µå°¡ »ý¼ºÇü AI ±â¼úÀ» Àû¿ëÇÑ »ó´ã Áö¿ø½Ã½ºÅÛÀ» ±¸ÃàÇÏ°í »õ·Î¿î °í°´ °æÇè Çõ½Å¿¡ ³ª¼±´Ù. ½ÅÇÑÄ«µå(»çÀå ¹ÚâÈÆ)´Â »ý¼ºÇü AI°¡ žÀçµÈ »õ·Î¿î »ó´ã Áö¿ø½Ã½ºÅÛ ‘AI-SOLa(¾ÆÀ̽ò¶ó)’¸¦ ±¸ÃàÇÏ°í °í°´ ÀÀ´ë Àü °úÁ¤¿¡ Àû¿ëÇÑ´Ù. ‘¾ÆÀ̽ò¶ó’´Â °í°´ÀÇ ´Ù¾çÇÑ ¹®ÀÇ ³»¿ëÀ» AI°¡ ½Ç½Ã°£À¸·Î ºÐ¼®ÇØ »ó´ã»ç¿¡°Ô ÃÖÀûÀÇ ¼Ö·ç¼ÇÀ» Á¦½ÃÇØ ÁÖ´Â AI »ó´ã Áö¿ø½Ã½ºÅÛÀÌ´Ù. °í°´°ú »ó´ã»ç °£ÀÇ ´ëÈ­ ³»¿ëÀ» ÅؽºÆ®·Î ½Ç½Ã°£ ÀüȯÇÏ´Â STT(Speech-to-Text) ±â¼úÀ» ±â¹ÝÀ¸·Î ÀÏ»ó ¾ð¾î¸¦ ÀÌÇØÇÏ°í, ¸Æ¶ô¿¡ °É¸Â ...

Çö´ëÂ÷, Àü±âÂ÷ ±¸¸Å °í°´ Â÷·® ±¸¸Å ÇýÅà °­È­

Àü±âÂ÷ 9°³ Â÷Á¾¿¡ ´ëÇØ 300~500¸¸¿ø ÇÒÀÎ
Çö´ëÂ÷°¡ ±¹³» Àü±âÂ÷ º¸±Þ È®´ë¿¡ ±â¿©ÇÏ°í °í°´ÀÇ Àü±âÂ÷ ±¸¸Å ºÎ´ãÀ» ¿ÏÈ­Çϱâ À§ÇÑ ÇÒÀÎ ÇÁ·Î¸ð¼ÇÀ» ÁøÇàÇÑ´Ù°í 5ÀÏ(¼ö) ¹àÇû´Ù. Çö´ëÂ÷´Â À̹ø ÇÁ·Î¸ð¼ÇÀ» ÅëÇØ Àü±âÂ÷ 9°³ Â÷Á¾¿¡ ´ëÇØ ±âº» Â÷·® °¡°Ý ÇÒÀο¡ ¿ùº° Àç°í ÇÒÀαîÁö ´õÇØ Â÷Á¾º° ÃÖ´ë 300~500¸¸¿øÀÇ Àü±âÂ÷ ±¸¸Å ÇýÅÃÀ» Áö¿øÇÑ´Ù. ´ë»ó Â÷Á¾ ¹× ÃÖ´ë ÇÒÀÎ ±Ý¾×Àº ¡ã¾ÆÀÌ¿À´Ð 5, ¾ÆÀÌ¿À´Ð 6 300¸¸¿ø ¡ãÄÚ³ª ÀÏ·ºÆ®¸¯ 400¸¸¿ø ¡ãÆ÷ÅÍ II ÀÏ·ºÆ®¸¯, ST1 500¸¸¿ø ¡ã¾ÆÀÌ¿À´Ð 5 N, ij½ºÆÛ ÀÏ·ºÆ®¸¯ 100¸¸¿øÀÌ´Ù. Á¦³×½Ã½ºÀÇ °æ¿ì GV60 300¸¸¿ø, G80 Àüµ¿È­ ¸ðµ¨ 5% °¡°Ý ...
»ó»óÀÌ Çö½ÇÀÌ µÇ´Â ¹Ù´Ù ¡®Á¦14ȸ È­¼º ¹î³îÀÌ ÃàÁ¦¡¯ (2024-06-01)
Åõ½æÇ÷¹À̽º, ºò»çÀÌÁî·Î Áñ±â´Â ¡®º¹¼þ¾Æ&·¹¸ó ¾Æ¼¦Ãß¡¯ ·ÐĪ (2024-07-07)
¹Ì°Ç¶óÀÌÇÁ, Àεµ ´ºµ¨¸®¿¡ ¹ýÀÎ ¼³¸³°ú Á÷¿µ ¼¾ÅÍ ¿ÀÇ (2024-07-30)
±¹³»Ã¢Ãâºñ¿ëÁö¿ø»ç¾÷ Âü°¡ ±â¾÷ ¸ðÁý (2016-11-04)
Kaitie Kramer Joins Parse Biosciences as Vice President of M... (2024-09-27)
Organon to Acquire Dermavant including its Innovative Dermat... (2024-09-27)
L&T Technology Services Unveils Cutting-Edge AI Experience Z... (2024-11-02)
NTT DATA Establishes Generative AI Talent Development Framew... (2024-11-02)
Alpega Introduces Connecta, Europe¡¯s First Open Logistics N... (2024-11-02)
ADx NeuroSciences and Alamar Biosciences Announce Partnershi... (2024-11-02)
Çö´ëÂ÷±×·ì 4°³»ç, ¡®°Ç°­Ä£È­±â¾÷¡¯ ÀÎÁõ ȹµæ (2023-12-18)
»ï¼º ºñ½ºÆ÷Å© ³ÃÀå°í, Ãâ½Ã 5³â ¸¸¿¡ ´©Àû ÆǸŠ300¸¸´ë µ¹ÆÄ (2024-07-01)
ìí ½ÅÄ«ÀÌ ¸¶ÄÚÅä ¡®Àç³­ 3ºÎÀÛ¡¯ °ø½Ä Çʸ§ Äܼ­Æ® (2024-01-20)
Axelspace Holdings Welcomes New Shareholders from CVC Funds ... (2024-09-24)
SCIVAX and Shin-Etsu Chemical Have Jointly Developed Amtelus... (2024-11-12)
°æÁ¦/°æ¿µ¼­ ¡®ÆÀ ¸®µù¡¯ Ãâ°£ (2023-10-05)
µÎ»ê¿¡³Êºô¸®Æ¼, Á¦Ã¶¼Ò¿¡µµ AI ±â¼ú Àû¿ëÇÑ´Ù (2024-07-21)
û³âÀÇ ¸¶À½Ã¬±è À§ÇÑ »õ·Î¿î ¹æÇâ - ¡®°ü°è¡¯ Å°¿öµå ÁÖ¸ñ (2024-07-21)
LSÀü¼±, ¹Ì±¹ ¼­ºÎ¿¡ 1000¾ï¿ø ÇØÀúÄÉÀÌºí °ø±Þ (2024-07-08)
±èÀ¯Á¤, ¹Ùºñ ºê¶ó¿î ¾Æ½Ã¾Æ ÆÛ½ÃÇÈ ºê·£µå ¾Ú¹ö¼­´õ ¹ßŹ (2024-08-13)
±è¹Î±Ô, ¡®Çü¾Æ¹Ù¶ó±â¡¯ µµ¼º´ë±ºÀ¸·Î µîÀå (2024-04-18)
乫ÀÚÀÇ °íÀÇÀûÀΠȸÇÇ´Â ¼Ò¸ê½ÃÈ¿ ÁÖÀå ¸ø ÇØ. (2013-12-12)
±èÈ«ÅÃ-¹ÚÁö¿µ, °°Àº ³¯ KLPGA/KPGA Á¦ÆÐ (2024-05-11)
Liminal Names Experian a Leader in Account Takeover Preventi... (2024-09-05)
Cancer Therapy: AOP Health Investigates a New Approach Targe... (2024-10-14)
       [ÀÌÀü][1]....[300][301][302][303][304][305][306][307][308]...[3433][´ÙÀ½]
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..